Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Health

Results: 1333-1344 of 9514

ONWARD Medical Reports Full Year 2025 Financial and Operating Results, Highlighting Strong US Commercial Performance and Major Pipeline Milestones

PR Newswire associated0

Amorepacific, Viol Medical Sign MOU on Beauty and Medical Devices

Business Wire logo

Provation Introduces Real-Time, AI-Powered Documentation Assist for GI Procedures

ACCESS Newswire logo

Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy

PR Newswire associated0

Viva Biotech Announces 2025 Annual Results: AI-Driven Drug Discovery Reinforces Industry Leadership, CDMO Commercial Products Enter Rapid Scale-Up

KLAS Research: 100% of surveyed customers would repurchase Vectramind Health Firstpass

Tigermed Announces 2025 Annual Results

ACCESS Newswire logo

Safe Staffing Requires New Models of Care, Not Just More Clinicians, Says Global Taskforce

PR Newswire associated0

Emboline Announces Positive Pivotal PROTECT H2H Trial Results for Emboliner® Presented as a Late-Breaking Clinical Trial at ACC 2026

HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics

HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)

PR Newswire associated0

CGBIO Showcases Minimally Invasive Spine Surgery Techniques in Thailand: "Smaller Incisions, Faster Recovery"

Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)

  • Prev Page
  • 1
  • 2
  • …
  • 111
  • 112
  • 113
  • …
  • 792
  • 793
  • Next Page

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us